Adderall Information
What is Adderall?
Adderall® is the name under which Shire markets a prescription medication for ADHD generically called D-Amphetamine Salt Combo. Sales of Adderall were suspended in Canada in February 2005 following reports of sudden deaths and cardiovascular problems in patients taking Adderall. At the time Health Canada suspended sales of Adderall, the US FDA issued a statement saying it was evaluating the data.
- FDA Advisory Panel Recommends Black Box Warning for Adderall and Other ADHD/ADD Drugs
- Sudden deaths, heart attacks, and strokes in both children and adults taking drugs to treat attention deficit hyperactivity disorder (ADHD) have been reported to the FDA. These adverse event reports led the agency to, in February 2006, convene an advisory panel committee of outside drug-safety experts.
- Adderall Sales Suspended by Health Canada
- In February 2005, Health Canada suspended sales of the once-daily formulation of the attention-deficit disorder drug Adderall, citing a risk that it may cause sudden deaths. Adderall is one of the most popular drugs for people with the widely-diagnosed condition more formally known as attention deficit hyperactivity disorder (ADHD).
- Public Health Advisory for Adderall and Adderall XR
- Health Canada, the Canadian drug regulatory agency, has suspended the sale of Adderall XR in the Canadian market. Adderall XR is a controlled release amphetamine used to treat patients with Attention Deficit Hyperactivity Disorder (ADHD). The Canadian action was based on U.S. post-marketing reports of sudden deaths in pediatric patients.
- FDA Statement on Adderall - February 2005
- FDA is aware of Health Canada's decision to suspend sales, but not revoke the approval in Canada, of the drug Adderall as a treatment for Attention Deficit and Hyperactivity Disorder (ADHD). FDA has been in close consultation with the Canadian authorities regarding the basis for their action.
- Canadian Advisory on Adderall
- Health Canada is informing Canadians that it has instructed Shire BioChem Inc., the manufacturer of ADDERALL XRŽ to withdraw the drug from the Canadian market. Health Canada has suspended the market authorization of the product due to safety information concerning the association of sudden deaths, heart-related deaths, and strokes in children and adults taking usual recommended doses of ADDERALLŽ and ADDERALL XRŽ.
- Adderall and Adderall XR Information at US FDA
- FDA ALERT [08/2005] Health Canada Announces Return of Adderall to the Canadian Market.
- FDA ALERT [02/2005] Health Canada Suspends Marketing of Adderall
- Adderall Class Actions
- Our law firm believes that people injured by Adderall are better served by having an individual lawsuit filed instead of joining a class action lawsuit.
- Adderall and Legal Compensation
- How to get legal compensation for an Adderall injury or death.
|
